{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:44:40Z","timestamp":1791420280212,"version":"4.3.3"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1053\/bega.1999.0067","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"173-192","source":"Crossref","is-referenced-by-count":8,"title":["Management of gastroduodenal ulcers caused by non-steroidal anti-inflammatory drugs"],"prefix":"10.1053","volume":"14","author":[{"given":"C.J.","family":"Hawkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/bega.1999.0067_RF1","unstructured":"Mann, C, C, Plummer, M, L, The Aspirin Wars"},{"key":"10.1053\/bega.1999.0067_RF2","first-page":"1222","article-title":"Gastroscopic observations of the effect of aspirin and certain other substances on the stomach","volume":"2","author":"Douthwaite","year":"1983","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0067_RF3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(86)92940-5","article-title":"Rising frequency of ulcer perforation in elderly people in the United Kingdom","volume":"1","author":"Walt","year":"1986","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0067_RF4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bmj.300.6720.278","article-title":"Non-steroidal anti-inflammatory drugs and ulcers: facts and figures multiply, but do they add up?","volume":"3000","author":"Hawkey","year":"1990","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.1999.0067_RF5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","article-title":"Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Langman","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0067_RF6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.312.7046.1563","article-title":"The ability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis","volume":"312","author":"Henry","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.1999.0067_RF7","first-page":"446","article-title":"Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer","volume":"1","author":"Somerville","year":"1986","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0067_RF8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archinte.1987.00370010087021","article-title":"The association of non-steroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding","volume":"147","author":"Carson","year":"1987","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.1999.0067_RF9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-114-4-257","article-title":"Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons","volume":"114","author":"Griffin","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.1999.0067_RF10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(91)90744-A","article-title":"Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs","volume":"32","author":"Laporte","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0067_RF11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding","volume":"310","author":"Weill","year":"1995","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.1999.0067_RF12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.37.4.509","article-title":"Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin\u2014analysis of gastrointestinal bleeding during the UK-TIA trial","volume":"37","author":"Slattery","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0067_RF13","unstructured":"Stack, W, A, Atherton, J, C, Hawkey, G, M, Risk factors for peptic ulcer bleeding in the era of low dose aspirin, Lancet"},{"key":"10.1053\/bega.1999.0067_RF14","first-page":"232","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature"},{"key":"10.1053\/bega.1999.0067_RF15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/gut.34.6.742","article-title":"Enhanced gastric mucosal leukotriene B4synthesis in patients taking non-steroidal inflammatory drugs","volume":"34","author":"Hudson","year":"1993","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0067_RF16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00001574-199611000-00003","article-title":"Gastroduodenal mucosal defense","volume":"12","author":"Wallace","year":"1996","journal-title":"Current Opinion in Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0016-5085(79)90235-X","article-title":"Cytoprotection by prostaglandins","volume":"77","author":"Robert","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF18","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1096\/fasebj.6.6.1544545","article-title":"Endothelin induces vascular and mucosal lesions, enhances the injury by HCl\/ethanol, and the antibody exerts gastroprotection","volume":"6","author":"Morales","year":"1992","journal-title":"FASEB Journal"},{"key":"10.1053\/bega.1999.0067_RF19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm0295-154","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) associated with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury","volume":"1","author":"Lichtenberger","year":"1995","journal-title":"Nature Medicine"},{"key":"10.1053\/bega.1999.0067_RF20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jps.2600580122","article-title":"Studies on the mechanism of action of salicylates. IV. Effect of salicylates on oxidative phosphorylation","volume":"58","author":"Thompkins","year":"1969","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1053\/bega.1999.0067_RF21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/00365517609054490","article-title":"Salicylate and aspirin-induced uncoupling of oxidative phosphorylation in mitochondria isolated from the mucosal membrane of the stomach","volume":"36","author":"Jorgensen","year":"1976","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1053\/bega.1999.0067_RF22","first-page":"540","article-title":"Absorption of drugs from the stomach","volume":"120","author":"Hogben","year":"1957","journal-title":"Human Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1053\/bega.1999.0067_RF23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0016-5085(64)80125-6","article-title":"Gastric mucosal injury by fatty acid and acetylsalicylic acids","volume":"46","author":"Davenport","year":"1964","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.bmb.a011662","article-title":"H. pylori virulence factors","volume":"54","author":"Atherton","year":"1998","journal-title":"British Medical Bulletin"},{"key":"10.1053\/bega.1999.0067_RF25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal anti-inflammatory drugs","volume":"338","author":"Yeomans","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0067_RF26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with non-steroidal anti-inflammatory drugs","volume":"338","author":"Hawkey","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0067_RF27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0016-5085(81)90196-7","article-title":"Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat","volume":"80","author":"Whittle","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1440-1681.1996.tb02754.x","article-title":"Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH","volume":"23","author":"Elliot","year":"1996","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1053\/bega.1999.0067_RF29","first-page":"A712","article-title":"Complete prevention by omeprazole of aspirin-induced gastric lesions in healthy subjects","volume":"29","author":"Bigard","year":"1988","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0067_RF30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/gut.31.5.514","article-title":"Abolition by omeprazole of aspirin-induced gastric mucosal injury in man","volume":"31","author":"Daneshmend","year":"1990","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0067_RF31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02090067","article-title":"Omeprazole ameliorates aspirin-induced gastroduodenal injury","volume":"39","author":"Scheiman","year":"1994","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.1999.0067_RF32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"COX-2 Inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0067_RF33","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/BF01308074","article-title":"Treatment of non-steroidal anti-inflammatory drug-induced gastric ulcers with misoprostol. A double-blind multicenter study","volume":"37","author":"Jaszewski","year":"1992","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.1999.0067_RF34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","article-title":"Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs","volume":"123","author":"Silverstein","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.1999.0067_RF35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archinte.1989.00390040017004","article-title":"Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin","volume":"149","author":"Roth","year":"1989","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.1999.0067_RF36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/gut.32.3.252","article-title":"Ranitidine in the treatment of non-steroidal anti-inflammatory drug-associated gastric and duodenal ulcers","volume":"32","author":"Lancaster-Smith","year":"1991","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0067_RF37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/32.11.990","article-title":"The prevention of healing of acute non-steroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol","volume":"32","author":"Bardhan","year":"1993","journal-title":"British Journal of Rhematology"},{"key":"10.1053\/bega.1999.0067_RF38","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1053\/gast.1997.v112.pm9178671","article-title":"Famotidine for healing and maintenance in non-steroidal anti-inflammatory drug-associated gastroduodenal ulceration","volume":"112","author":"Hudson","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF39","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM199605303342204","article-title":"Famotidine for the prevention of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs","volume":"334","author":"Taha","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0067_RF40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198901123200201","article-title":"Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer","volume":"320","author":"Walan","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0067_RF41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/gut.41.1.19","article-title":"Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans","volume":"41","author":"Hudson","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0067_RF42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Helicobacter pylori eradication in patients taking non-steroidal, anti-inflammatory drugs: the HELP NSAIDs Study","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0067_RF43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gut.37.6.743","article-title":"Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole","volume":"37","author":"Verdu","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0067_RF44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/gut.41.1.33","article-title":"Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer","volume":"41","author":"Labenz","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0067_RF45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archinte.1996.00440190069008","article-title":"Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomised controlled clinical trials","volume":"156","author":"Koch","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.1999.0067_RF46","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1007\/BF01309338","article-title":"A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects","volume":"31","author":"Lanza","year":"1986","journal-title":"Digestive Diseases and Science"},{"key":"10.1053\/bega.1999.0067_RF47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(87)90577-8","article-title":"Protection by misoprostol against naproxen-induced gastric mucosal damage","volume":"83","author":"Aadland","year":"1987","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.1999.0067_RF48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0016-5085(88)90482-9","article-title":"A double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum","volume":"95","author":"Lanza","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF49","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(88)92892-9","article-title":"Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial","volume":"2","author":"Graham","year":"1988","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0067_RF50","first-page":"119","article-title":"Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis","volume":"23","author":"Saggiror","year":"1991","journal-title":"Italian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF51","first-page":"1743","article-title":"Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofen-associated lesions","volume":"86","author":"Geis","year":"1991","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/bega.1999.0067_RF52","first-page":"143","article-title":"A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulcerations","volume":"83","author":"Lanza","year":"1988","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009749209095074","article-title":"A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis","volume":"21","author":"Verdickt","year":"1992","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1053\/bega.1999.0067_RF54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/03009749409103056","article-title":"Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers: a placebo-controlled trial","volume":"23","author":"Elliot","year":"1994","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1053\/bega.1999.0067_RF55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-119-4-199308150-00001","article-title":"Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs","volume":"119","author":"Graham","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.1999.0067_RF56","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1007\/BF01309407","article-title":"Overview of clinical safety with misoprostol","volume":"30","author":"Herting","year":"1985","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.1999.0067_RF57","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3109\/00365529008997630","article-title":"Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes: a double-blind, placebo-controlled, multicentre study","volume":"25","author":"Hausken","year":"1990","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2036.1988.tb00767.x","article-title":"Treatment of endoscopy negative NSAID-induced upper gastrointestinal symptoms with cimetidine: an international collaborative study","volume":"2","author":"Bijlsma","year":"1988","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0067_RF59","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2036.1992.tb00735.x","article-title":"Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin","volume":"6","author":"Cole","year":"1992","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0067_RF60","first-page":"223","article-title":"Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study","volume":"91","author":"Raskin","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF61","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/bmj.297.6655.1017","article-title":"Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine","volume":"297","author":"Ehsanullah","year":"1988","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.1999.0067_RF62","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004836-198606002-00009","article-title":"Reduction of aspirin-induced gastroduodenal mucosal damage with ranitidine","volume":"8","author":"Berkowitz","year":"1986","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF63","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF01536266","article-title":"Effect of ranitidine on gastroduodenal mucosal damage induced by non-steroidal anti-inflammatory drugs","volume":"34","author":"Robinson","year":"1989","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.1999.0067_RF64","first-page":"540S","article-title":"Why are non-steroidal anti-inflammatory drugs important in peptic ulceration?","author":"Bianchi Porro","year":"1987","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0067_RF65","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/archinte.1993.00410210073008","article-title":"Nizatidine prevents peptic ulceration in high-risk patients taking non-steroidal anti-inflammatory drugs","volume":"153","author":"Levine","year":"1993","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/bega.1999.0067_RF66","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0016-5085(89)91502-3","article-title":"Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine","volume":"97","author":"Daneshmend","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF67","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199402103300602","article-title":"A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer","volume":"330","author":"Jensen","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0067_RF68","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00001648-199905000-00006","article-title":"Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed","volume":"10","author":"Garcia Rodriguez","year":"1999","journal-title":"Epidemiology"},{"key":"10.1053\/bega.1999.0067_RF69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001648-199905000-00003","article-title":"Omeprazole and bleeding peptic ulcer, or \u2018How case-control studies can tell you what you suspected all along\u2019","volume":"10","author":"Hawkey","year":"1999","journal-title":"Epidemiology"},{"key":"10.1053\/bega.1999.0067_RF70","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529609010347","article-title":"Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study","volume":"31","author":"Ekstrom","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","article-title":"Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users","volume":"12","author":"Cullen","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0067_RF72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-115-3-195","article-title":"Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial","volume":"115","author":"Agrawal","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.1999.0067_RF73","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2036.1993.tb00127.x","article-title":"Ranitidine bismuth citrate and aspirin-induced mucosal injury","volume":"7","author":"Hudson","year":"1993","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0067_RF74","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/S0140-6736(97)04523-6","article-title":"Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drugs therapy to prevent peptic ulcers","volume":"350","author":"Chan","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0067_RF75","doi-asserted-by":"crossref","first-page":"A87","DOI":"10.1016\/S0016-5085(98)80353-3","article-title":"Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer haemorrhage in high risk NSAID users: a prospective randomised study","volume":"114","author":"Chan","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF76","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/jm960803q","article-title":"Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cylcooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazole-1-yljbenze nesulfonamide (SC-58635, celecoxib)","volume":"40","author":"Penning","year":"1997","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1053\/bega.1999.0067_RF77","unstructured":"FDA website for celecoxib, http:\/\/www.fda.gov\/cder\/foi\/label\/1998\/20998ibi.pdf"},{"key":"10.1053\/bega.1999.0067_RF78","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J","article-title":"Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase-2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects","volume":"41","author":"Simon","year":"1998","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/bega.1999.0067_RF79","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0009-9236(99)70113-X","article-title":"Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model","volume":"65","author":"Ehrich","year":"1999","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0067_RF80","unstructured":"FDA web site for rofecoxib, http:\/\/www.fda.gov\/cder\/foi\/label\/1999\/21042lbl.pdf"},{"key":"10.1053\/bega.1999.0067_RF81","first-page":"A194","article-title":"Selective inhibition of cyclooxygenase-2 (COX-2) with MK-0966 (250mg qd) is associated with less gastroduodenal damage than aspirin ASA 650mg qid or ibuprofen (IBU) 800mg tid","volume":"112","author":"Lanza","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0067_RF82","unstructured":"Laine, L, Harper, S, Simon, T, A randomized trial comparing the effect of rofecoxib, a COX-2 specific inhibitor, to ibuprofen on the gastroduodenal mucosa of osteoarthritis patients"},{"key":"10.1053\/bega.1999.0067_RF83","unstructured":"Hawkey, C, J, A comparison of the effect of rofecoxib (a COX-2 specific inhibitor), ibuprofen, or placebo on the gastroduodenal mucosa of osteoarthritis patients, Arthritis and Rheumatism"},{"key":"10.1053\/bega.1999.0067_RF84","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2165\/00003495-199651030-00007","article-title":"Meloxicam","volume":"51","author":"Nobel","year":"1996","journal-title":"Drugs"},{"key":"10.1053\/bega.1999.0067_RF85","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/37.9.937","article-title":"Gastrointestinal tolerability of the COX-2 inhibitor, meloxicam, in osteoarthritis patients: the meloxicam large scale international study safety assessment (MELISSA)","volume":"37","author":"Hawkey","year":"1998","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/bega.1999.0067_RF86","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/rheumatology\/37.9.946","article-title":"Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam compared with piroxicam: results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (SELECT) trial in osteoarthritis","volume":"37","author":"Dequeker","year":"1998","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/bega.1999.0067_RF87","first-page":"1093","article-title":"Activity of nimesulide on constitutive and inducible cyclooxygenases","volume":"45","author":"Tavares","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1053\/bega.1999.0067_RF88","first-page":"521","article-title":"Etodolac selectivity inhibits human prostaglandin G\/H synthase 2 (PGHS-2) versus human PGHS-1","volume":"346","author":"Glaser","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1053\/bega.1999.0067_RF89","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1139\/y97-130","article-title":"Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors using sensitive microsomal and platelet assays","volume":"75","author":"Riendeau","year":"1997","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1053\/bega.1999.0067_RF90","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0009-9236(95)90251-1","article-title":"Effects of nabumetone on prostanoid synthesis in humans","volume":"58","author":"Cipollone","year":"1995","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0067_RF91","first-page":"A33","article-title":"Low dose misoprostol as prophylaxis against low dose aspirin-induced gastroduodenal mucosal injury","volume":"39","author":"Goddard","year":"1996","journal-title":"Gut"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691899900677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691899900677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T21:11:19Z","timestamp":1581023479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691899900677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S1521691899900677"],"URL":"https:\/\/doi.org\/10.1053\/bega.1999.0067","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}